Fund Holdings — Camber Capital Management LP

Total Portfolio Value:
$2.86M
Total Bought:
$299.0K
Total Sold:
$384.4K
Net Transaction:
-$85.4K
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Zimmer Biomet Holdings, Inc.(ZBH)1,925,0001,925,0000$234.3K$254.1K8.88%+$19.8K
Universal Health Services, Inc.CL B(UHS)1,870,0001,250,000-620,000$285.1K$228.1K7.97%-$57.0K
Baxter Intl Inc5,000,0005,000,0000$193.3K$213.7K7.47%+$20.4K
Tenet Healthcare Corporation(THC)3,745,0001,900,000-1,845,000$283.0K$199.7K6.98%-$83.3K
Viatris Inc.(VTRS)18,500,00016,250,000-2,250,000$200.4K$194.0K6.78%-$6.3K
Walgreens Boots Alliance Inc7,000,0007,800,000+800,000$182.8K$169.2K5.91%-$13.6K
Myriad Genetics, Inc.(MYGN)7,635,0007,635,0000$146.1K$162.8K5.69%+$16.6K
Medtronic plcSHS(MDT)1,850,0001,850,0000$152.4K$161.2K5.64%+$8.8K
Jazz Pharmaceuticals plcSHS USD(JAZZ)675,0001,150,000+475,000$83.0K$138.5K4.84%+$55.5K
Globus Medical, Inc.CL A(GMED)2,250,0002,500,000+250,000$119.9K$134.1K4.69%+$14.2K
PTC Therapeutics, Inc.(PTCT)4,000,0004,000,0000$110.2K$116.4K4.07%+$6.1K
Select Med Hldgs Corp3,400,0003,400,0000$79.9K$102.5K3.58%+$22.6K
Brookdale Senior Living Inc.(BKD)15,500,00015,500,0000$90.2K$102.5K3.58%+$12.2K
GSK plcADR(GSK)2,175,0002,175,0000$80.6K$93.2K3.26%+$12.6K
Biogen Inc.(BIIB)0400,000+400,000$0$86.3K3.02%+$86.3K
Sarepta Therapeutics, Inc.(SRPT)800,000585,000-215,000$77.1K$75.7K2.65%-$1.4K
Zimvie Inc3,250,0003,250,0000$57.7K$53.6K1.87%-$4.1K
Qiagen N.V.SHS NEW(QGEN)01,210,000+1,210,000$0$52.0K1.82%+$52.0K
Perrigo Company plcSHS(PRGO)1,850,0001,520,000-330,000$59.5K$48.9K1.71%-$10.6K
Collegium Pharmaceutical, Inc.(COLL)1,050,000852,900-197,100$32.3K$33.1K1.16%+$791
Denali Therapeutics Inc.(DNLI)01,500,000+1,500,000$0$30.8K1.08%+$30.8K
Herbalife Ltd.(HLF)2,000,0003,000,000+1,000,000$30.5K$30.1K1.05%-$370
OraSure Technologies, Inc.(OSUR)4,250,0004,250,0000$34.9K$26.1K0.91%-$8.7K
Brookdale Senior Living Inc.UNIT 11 15 2025(BKD)250,000250,0000$20.3K$22.7K0.79%+$2.4K
Replimune Group, Inc.(REPL)1,000,0002,750,000+1,750,000$8.4K$22.5K0.79%+$14.0K
BioMarin Pharmaceutical Inc.(BMRN)0250,000+250,000$0$21.8K0.76%+$21.8K
Peloton Interactive, Inc.CL A(PTON)4,500,0004,500,0000$27.4K$19.3K0.67%-$8.1K
Inogen, Inc.(INGN)2,000,0002,000,0000$11.0K$16.1K0.56%+$5.2K
SkinHealth Systems Inc.CL A(SKIN)3,500,0003,500,0000$10.9K$15.5K0.54%+$4.7K
Bicycle Therapeutics PlcADS450,000450,0000$8.1K$11.2K0.39%+$3.1K
Theravance Biopharma Inc01,000,000+1,000,000$0$9.0K0.31%+$9.0K
Puma Biotechnology, Inc.(PBYI)2,805,0001,650,000-1,155,000$12.1K$8.7K0.31%-$3.4K
Curevac N V1,750,0001,750,0000$7.4K$5.3K0.19%-$2.1K
Genmab A/SADS(GMAB)050,000+50,000$0$1.5K0.05%+$1.5K
Ascendis Pharma A/SSPONSORED ADR(ASND)165,0000-165,000$20.8K$0—-$20.8K
Harmony Biosciences Holdings, Inc.COM(HRMY)750,0000-750,000$24.2K$0—-$24.2K
Ionis Pharmaceuticals, Inc.COM(IONS)865,0000-865,000$43.8K$0—-$43.8K
Moderna, Inc.COM(MRNA)250,0000-250,000$24.9K$0—-$24.9K
Qiagen N.V.SHS NEW(QGEN)615,0000-615,000$26.7K$0—-$26.7K
QuidelOrtho CorporationCOM(QDEL)400,0000-400,000$29.5K$0—-$29.5K
SOLID BIOSCIENCES INCCOM NEW1,418,4390-1,418,439$8.7K$0—-$8.7K
Ultragenyx Pharmaceutical Inc.COM(RARE)900,0000-900,000$43.0K$0—-$43.0K
Page 1 of 1
Camber Capital Management LP — 13F Holdings — Q1 2024 | TickerTrail